Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification

AIM: Randomized pilot study comparing clinical outcomes with bromfenac ophthalmic solution 0.07% versus nepafenac 0.3% ophthalmic suspension administered as identical dosing regimens in patients undergoing uncomplicated phacoemulsification with intraocular lens implantation. METHODS: Forty-nine subj...

Descripción completa

Detalles Bibliográficos
Autor principal: Toyos, Melissa M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513915/
https://www.ncbi.nlm.nih.gov/pubmed/30868419
http://dx.doi.org/10.1007/s40123-019-0174-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6513915/
https://www.ncbi.nlm.nih.gov/pubmed/30868419
http://dx.doi.org/10.1007/s40123-019-0174-x

Ejemplares similares